ATAC - Endometrial Sub-Protocol

NCT00814125 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Anastrozole (Arimidex)
DRUG: Tamoxifen (Nolvadex)
DRUG: Nolvadex placebo
DRUG: Arimidex placebo

Sponsor

AstraZeneca